We also note that bundling the monthly formulation of Brixadi into the existing HCPCS code (G2069) for injectable buprenorphine would be appropriate and no more administratively complex for OTPs since G2069 is already billed on a monthly basis
Section 4114(a) of the CAA, 2023 further amended section 1834A(b)(3)(B)(iii) of the Act to state that the applicable percent of 15 percent will apply for CYs 2024 through 2026, instead of CYs 2023 through 2025
Chewing tobacco may be flavored
( 16 ) 99484, 99492, 99493 and 99494 (codes for behavioral health integration services)
We also reviewed feedback from hookah enthusiasts and regular smokers
(2) For a Part B rebatable drug first approved or licensed by the FDA after December 1, 2020, the payment amount benchmark quarter is the third full calendar quarter after a drug's first marketed date